Evotec Adds To Spate Of Metabolic Deals With Lilly Collaboration

Potential $1bn Deal Value

 
• By Ayisha Sharma

The German biotech inks its fifth metabolic disease collaboration as it teams up with US major Lilly to develop kidney disease and diabetes assets.  

sugar cubes with an syringe as a symbol for diabetes
The partnership will focus on drug development for diabetes and kidney diseases. • Source: Alamy

More from Deals

More from Business